Skip to main content
. 2016 Nov 11;10:3685–3698. doi: 10.2147/DDDT.S102141

Figure 3.

Figure 3

Proposed algorithm for use of UST in moderate-to-severe Crohn’s disease.

Abbreviations: UST, ustekinumab; VDZ, vedolizumab; AEs, adverse events; TNF, tumor necrosis factor; CD, Crohn’s disease.